World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
15052
World Ranking
3938
National Ranking
1804

Best Publications

  • Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

    Unknown

  • Antiretroviral Regimens in Pregnancy and Breast-Feeding in Botswana

    R. L. Shapiro;A. Ogwu;D. Kitch;S. Lockman

  • Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.

    Ibou Thior;Shahin Lockman;Laura M Smeaton;Roger L Shapiro

  • Adaptation of HIV-1 to human leukocyte antigen class I

    Y. Kawashima;K. Pfafferott;J. Frater;P. Matthews

  • Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine

    Shahin Lockman;Roger L Shapiro;Laura M Smeaton;Carolyn Wester

  • Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception

    Rebecca Zash;Joseph Makhema;Roger L. Shapiro

  • Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana

    Rebecca Zash;Lewis Holmes;Modiegi Diseko;Denise L. Jacobson

  • Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

    Jennifer Y. Chen;Heather J. Ribaudo;Sajini Souda;Natasha Parekh

  • Selection bias at the heterosexual HIV-1 transmission bottleneck

    Jonathan M. Carlson;Malinda Schaefer;Daniela C. Monaco;Rebecca Batorsky

  • Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.

    Kathryn E. Stephenson;Kathryn E. Stephenson;Mathieu Le Gars;Jerald Sadoff;Anne Marit de Groot

  • Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor-Based HAART During Pregnancy

    Kathleen M. Powis;Douglas Kitch;Anthony Ogwu;Michael D. Hughes

  • Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor–Based HAART During Pregnancy

    Kathleen M. Powis;Douglas Kitch;Anthony Ogwu;Michael D. Hughes

  • Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana

    Joseph Makhema;Kathleen E Wirth;Molly Pretorius Holme;Tendani Gaolathe

  • Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.

    Rebecca Zash;Denise L. Jacobson;Modiegi Diseko;Gloria Mayondi

  • Infant Morbidity, Mortality, and Breast Milk Immunologic Profiles among Breast-Feeding HIV-Infected and HIV-Uninfected Women in Botswana

    Roger L Shapiro;Shahin Lockman;Soyeon Kim;Laura Smeaton

  • Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

    Unknown

  • Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study

    Rebecca Zash;Denise L Jacobson;Modiegi Diseko;Gloria Mayondi

  • Widespread Impact of HLA Restriction on Immune Control and Escape Pathways of HIV-1

    Jonathan M. Carlson;Jennifer Listgarten;Nico Pfeifer;Vincent Tan

  • Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

    Shahin Lockman;Shahin Lockman;Sean S Brummel;Lauren Ziemba;Lynda Stranix-Chibanda

  • Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.

    Unknown

Frequent Co-Authors

Stuart T. Hauser
Stuart T. Hauser Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Roger L. Shapiro